Can You Have a Normal Pregnancy with Lupus?
At a Glance
Yes, you can have a healthy pregnancy with lupus. The safest approach is waiting until your lupus has been well-controlled for at least six months. You will also need to adjust your medications with your rheumatologist and be monitored by a high-risk obstetrician to prevent complications.
In this answer
5 sections
Yes, having a successful, healthy baby is entirely possible when you have systemic lupus erythematosus (SLE) [1]. Decades ago, women with lupus were frequently advised against getting pregnant. Today, modern medical care makes it very achievable. However, because lupus can increase the risk of complications for both the mother and the baby, a safe pregnancy requires strict family planning, medication adjustments, and a dedicated healthcare team [2][1].
The “Six-Month Rule”: Timing Your Pregnancy
The single most important factor for a healthy pregnancy is the status of your lupus at the time of conception [1]. Trying to conceive during an active lupus flare drastically increases the risk of serious complications, including premature birth, preeclampsia, and fetal loss [3][1].
Because of this, rheumatologists strongly recommend that you only attempt pregnancy after achieving at least six months of stable, low disease activity—often called Lupus Low Disease Activity State (LLDAS)—or complete remission [4][5]. Entering pregnancy with calm, well-controlled lupus is the best way to protect both your health and your baby’s development [1].
Adjusting Your Medications Before Conception
Before you stop taking birth control, your doctor must review your medication list. Several powerful immunosuppressants commonly used to treat lupus are teratogenic (meaning they can cause severe birth defects) and must be completely cleared from your system well before you try to conceive [6][7]. These medications include:
- Mycophenolate mofetil (CellCept)
- Cyclophosphamide (Cytoxan)
- Methotrexate
- Leflunomide
The “washout period” for these drugs generally takes several weeks to several months, depending on the medication [8]. During this time, you will need to use a reliable form of contraception (note that estrogen-containing birth control is usually avoided if you have a history of blood clots or antiphospholipid antibodies) [9].
Discontinuing immunosuppressants without a backup plan can trigger a dangerous disease flare [7]. To keep your lupus controlled, your rheumatologist will transition you to pregnancy-compatible alternatives, such as azathioprine or calcineurin inhibitors like tacrolimus and cyclosporine, which are proven safe for fetal development [10][11].
The Foundation of a Lupus Pregnancy: Hydroxychloroquine
While some medications must be stopped, one medication is almost universally continued: hydroxychloroquine (Plaquenil) [12]. Unless you have a specific allergy or intolerance, this medication is the standard of care before, during, and after pregnancy [13].
Hydroxychloroquine is safe for the baby and provides vital benefits:
- It actively reduces lupus disease activity and prevents flares during pregnancy [14].
- It lowers the risk of maternal infections [15].
- If you carry anti-SSA/Ro or anti-SSB/La antibodies, hydroxychloroquine significantly reduces the risk of a rare complication called congenital heart block, where the baby’s heart beats abnormally slowly [16][17].
Understanding Specific Risks and Monitoring
A lupus pregnancy is always considered high-risk, meaning you will need a multidisciplinary team. This typically includes your rheumatologist and a Maternal-Fetal Medicine (MFM) specialist (an obstetrician who specializes in high-risk pregnancies) [18]. Expect to have more frequent appointments and ultrasounds than a standard pregnancy.
Your team will closely monitor you for specific lupus-related factors:
- Preeclampsia Prevention: Because lupus increases the risk of preeclampsia (dangerous high blood pressure in pregnancy), guidelines recommend that almost all pregnant women with lupus take daily low-dose aspirin as a preventative measure [19][1].
- Antiphospholipid Syndrome (APS): Some people with lupus carry antiphospholipid antibodies that increase the risk of blood clots and miscarriage [9]. If you test positive for these, your doctor will likely prescribe a blood thinner like heparin in addition to aspirin to protect the pregnancy [20][17].
- Kidney Health: A history of lupus nephritis (kidney inflammation) or chronic high blood pressure are major predictors of pregnancy complications [1][21]. Your team will monitor your urine and blood pressure frequently.
- Fetal Heart Monitoring: If you carry anti-SSA/Ro antibodies, your doctor will order specialized fetal echocardiograms (ultrasounds of the baby’s heart) starting in the second trimester to detect early signs of heart rhythm problems [22].
The Postpartum Period: Staying Vigilant After Delivery
The need for close monitoring does not end once the baby is born. The postpartum period (the weeks immediately following delivery) is a well-documented, high-risk window for severe lupus flares [18][19]. It is crucial that you continue taking your prescribed medications, such as hydroxychloroquine, after delivery to maintain your health as you recover and care for your newborn [14].
Common questions in this guide
What is the six-month rule for a lupus pregnancy?
Do I need to change my lupus medications before getting pregnant?
Is it safe to take hydroxychloroquine (Plaquenil) while pregnant?
What are the risks of having antiphospholipid antibodies during pregnancy?
Will my lupus flare up after I give birth?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Am I currently in a state of Lupus Low Disease Activity State (LLDAS) or remission, and how long has my condition been stable?
- 2.What is my current antibody profile, specifically regarding anti-SSA/Ro and antiphospholipid antibodies, and how does this affect my pregnancy plan?
- 3.Which of my current medications need to be washed out before conception, and how many weeks or months will that process take?
- 4.What pregnancy-compatible immunosuppressant can we transition to while we wait for the six-month mark to ensure I do not flare?
- 5.Can you refer me to a Maternal-Fetal Medicine (MFM) specialist who has significant experience managing lupus pregnancies?
- 6.What is our plan for monitoring and preventing disease flares during the high-risk postpartum period?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (22)
- 1
Pregnancy outcome predictors in systemic lupus erythematosus: a systematic review and meta-analysis.
Wind M, Fierro JJ, Bloemenkamp KWM, et al.
The Lancet. Rheumatology 2024; (6(10)):e667-e683 doi:10.1016/S2665-9913(24)00160-7.
PMID: 39153486 - 2
Systemic Lupus Erythematosus and Pregnancy: a Portuguese Case-Control Study.
Braga A, Barros T, Faria R, et al.
Clinical reviews in allergy & immunology 2022; (62(2)):324-332 doi:10.1007/s12016-021-08893-y.
PMID: 34519994 - 3
Systemic lupus erythematosus and risk of preterm birth: a systematic review and meta-analysis of observational studies.
Wei S, Lai K, Yang Z, Zeng K
Lupus 2017; (26(6)):563-571 doi:10.1177/0961203316686704.
PMID: 28121241 - 4
Lupus low disease activity state within 12 months is associated with favourable outcomes in severely active systemic lupus erythematosus.
Kikuchi J, Hanaoka H, Saito S, et al.
Rheumatology (Oxford, England) 2022; (61(9)):3777-3791 doi:10.1093/rheumatology/keac002.
PMID: 35015824 - 5
Validation of the revised definition of lupus low disease activity in patients with SLE.
Kang JH, Choi SE, Park DJ, Lee SS
Rheumatology (Oxford, England) 2026; (65(2)) doi:10.1093/rheumatology/keag052.
PMID: 41609430 - 6
Systemic Lupus Erythematosus Management in Pregnancy.
Dao KH, Bermas BL
International journal of women's health 2022; (14()):199-211 doi:10.2147/IJWH.S282604.
PMID: 35210867 - 7
Immunosuppressant use and adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective cohort study in Korea.
Jung YS, Song YJ, Jang EJ, et al.
Rheumatology (Oxford, England) 2026; (65(2)) doi:10.1093/rheumatology/keaf651.
PMID: 41385297 - 8
Treatment considerations in myasthenia gravis for the pregnant patient.
Gilhus NE
Expert review of neurotherapeutics 2023; (23(2)):169-177 doi:10.1080/14737175.2023.2178302.
PMID: 36786092 - 9
Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.
Vandevelde A, Chayoua W, de Laat B, et al.
Journal of thrombosis and haemostasis : JTH 2022; (20(9)):2136-2150 doi:10.1111/jth.15785.
PMID: 35713971 - 10
Calcineurin inhibitors in the treatment of systemic lupus erythematosus during pregnancy: A narrative review with emphasis on efficacy and safety.
Jiang Y, Tao M, Chen J, et al.
European journal of obstetrics, gynecology, and reproductive biology 2024; (294()):148-155 doi:10.1016/j.ejogrb.2023.12.039.
PMID: 38245953 - 11
Effectiveness and safety of hydroxychloroquine therapy with or without corticosteroid in patients with systemic lupus erythematosus.
Miyagawa I, Nakano K, Nakayamada S, et al.
International journal of rheumatic diseases 2019; (22(3)):434-442 doi:10.1111/1756-185X.13387.
PMID: 30338639 - 12
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Fanouriakis A, Kostopoulou M, Andersen J, et al.
Annals of the rheumatic diseases 2024; (83(1)):15-29 doi:10.1136/ard-2023-224762.
PMID: 37827694 - 13
Systemic Lupus Erythematosus: A Review.
Siegel CH, Sammaritano LR
JAMA 2024; (331(17)):1480-1491 doi:10.1001/jama.2024.2315.
PMID: 38587826 - 14
Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis.
Zhu Q, Wang J, Sun Q, et al.
Lupus science & medicine 2024; (11(2)) doi:10.1136/lupus-2024-001239.
PMID: 39477333 - 15
Infection vulnerability in pregnant women with and without systemic lupus erythematosus.
Khogali HI, Alhebsi AM, Altamimi MA, et al.
Lupus 2025; (34(7)):705-712 doi:10.1177/09612033251344195.
PMID: 40396629 - 16
Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.
Izmirly P, Kim M, Friedman DM, et al.
Journal of the American College of Cardiology 2020; (76(3)):292-302 doi:10.1016/j.jacc.2020.05.045.
PMID: 32674792 - 17
Hydroxychloroquine in systemic lupus erythematosus, anti-SSA/SSB, and antiphospholipid antibody-positive pregnancies.
Saleh ZF, Somers EC, Romero VC, Marder W
American journal of obstetrics and gynecology 2026; (234(1)):7-20 doi:10.1016/j.ajog.2025.09.002.
PMID: 40930382 - 18
Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy.
Hirashima C, Ogoyama M, Abe M, et al.
CEN case reports 2019; (8(2)):95-100 doi:10.1007/s13730-018-0373-7.
PMID: 30565047 - 19
Atypical preeclampsia with systemic lupus erythematosus and elevated soluble fms-like tyrosine kinase 1/placental growth factor ratio.
Mimura K, Tomimatsu T, Endo M, Kimura T
The journal of obstetrics and gynaecology research 2021; (47(12)):4461-4466 doi:10.1111/jog.15055.
PMID: 34605122 - 20
Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosus.
Uthurriague M, Lazaro E, Richez C, et al.
Expert review of clinical pharmacology 2025; (18(10)):1-17 doi:10.1080/17512433.2025.2573783.
PMID: 41066693 - 21
Impact of Systemic Lupus Erythematosus on Pregnancy: Analysis of a Large 10-Year Longitudinal Mexican Cohort.
Miranda-Hernández D, Sánchez A, Sánchez-Briones RE, et al.
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(6S)):S217-S223 doi:10.1097/RHU.0000000000001626.
PMID: 33264243 - 22
Congenital Complete Atrioventricular Heart Block in a Pregnant Woman with Sjögren Syndrome: Prenatal Care Follow-Up and the Challenge of Intrauterine Treatment.
Carrilho MC, Bravo-Valenzuela NJ, Araujo Júnior E
Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2020; (42(4)):228-232 doi:10.1055/s-0040-1709738.
PMID: 32330965
This information is for educational purposes and does not replace professional medical advice. Always consult your rheumatologist and obstetrician before attempting pregnancy or changing your lupus medications.
Get notified when new evidence is published on Systemic lupus erythematosus.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.